Prostaglandin release from macrophages: an assay system for anti-inflammatory drugs in vitro.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMID 596316)

Published in Agents Actions on September 01, 1977

Authors

M Glatt, H Kälin, K Wagner, K Brune

Articles by these authors

Oxygen status of lung granulomas in Mycobacterium tuberculosis-infected mice. J Pathol (2006) 2.20

Predictive diagnosis of the cancer prone Li-Fraumeni syndrome by accident: new challenges through whole genome array testing. J Med Genet (2009) 2.00

Maternal methylation imprints on human chromosome 15 are established during or after fertilization. Nat Genet (2001) 1.97

Assessment of phagocytic and antimicrobial activity of human granulocytes. Infect Immun (1974) 1.96

Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood (1994) 1.95

Quantitative detection of Borrelia burgdorferi by real-time PCR. J Clin Microbiol (1999) 1.93

The venous graft as an effector of early angiogenesis in a fibrin matrix. Microvasc Res (2007) 1.93

Histone acetylation and chromatin remodeling. Exp Cell Res (2001) 1.85

Women encounter ADRs more often than do men. Eur J Clin Pharmacol (2008) 1.83

HTLV-III antibodies in patients with kidney transplants or on haemodialysis. Lancet (1986) 1.81

Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis. Neurology (2008) 1.80

On the role of type IX collagen in the extracellular matrix of cartilage: type IX collagen is localized to intersections of collagen fibrils. J Cell Biol (1986) 1.67

DNA condensation in two dimensions. Proc Natl Acad Sci U S A (2000) 1.62

Transfusion errors in New York State: an analysis of 10 years' experience. Transfusion (2000) 1.62

Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylactogenic anti-IgE antibody. J Exp Med (1996) 1.61

Expectations and quality of life of cancer patients undergoing radiotherapy. J R Soc Med (2000) 1.61

A rat model of bone cancer pain. Pain (2002) 1.61

Gastrointestinal ulcerations induced by anti-inflammatory drugs in rats. Physicochemical and biochemical factors involved. Arch Toxicol (1990) 1.59

Recurrent genetic aberrations in thymoma and thymic carcinoma. Am J Pathol (2000) 1.53

Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting. Drug Saf (2000) 1.51

Weak localization in ferromagnetic (Ga,Mn)as nanostructures. Phys Rev Lett (2007) 1.50

The Wada test in Austrian, Dutch, German, and Swiss epilepsy centers from 2000 to 2005: a review of 1421 procedures. Epilepsy Behav (2008) 1.50

The oral multitarget tumour growth inhibitor, ZK 304709, inhibits growth of pancreatic neuroendocrine tumours in an orthotopic mouse model. Gut (2008) 1.49

Late onset Charcot-Marie-Tooth 2 syndrome caused by two novel mutations in the MPZ gene. Neurology (2003) 1.48

Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin. Proc Natl Acad Sci U S A (2000) 1.47

Cellular functions of 14-3-3 zeta in apoptosis and cell adhesion emphasize its oncogenic character. Oncogene (2007) 1.45

Simultaneous production of interleukin 2, interleukin 4 and interferon-gamma by activated human blood lymphocytes. Eur J Immunol (1990) 1.44

Molecular and clinical findings in Austrian cystic fibrosis patients with mutations in exon 11 of the CFTR gene. Wien Klin Wochenschr (1995) 1.44

Pharmacological control of prostaglandin and thromboxane release from macrophages. Nature (1978) 1.44

Readmissions and adverse drug reactions in internal medicine: the economic impact. J Intern Med (2004) 1.42

Importance of Kupffer cells for T-cell-dependent liver injury in mice. Am J Pathol (2000) 1.42

Peroxidaseless chicken leukocytes: isolation and characterization of antibacterial granules. J Infect Dis (1973) 1.39

Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour. Br J Cancer (2005) 1.39

Characterization of a novel 21-kb deletion, CFTRdele2,3(21 kb), in the CFTR gene: a cystic fibrosis mutation of Slavic origin common in Central and East Europe. Hum Genet (2000) 1.37

Disruption of a novel gene (IMMP2L) by a breakpoint in 7q31 associated with Tourette syndrome. Am J Hum Genet (2001) 1.37

Constitutive expression of the granulocyte-macrophage colony-stimulating factor gene in acute myeloblastic leukemia. J Clin Invest (1987) 1.37

Inhibition of anti-inflammatory drugs of prostaglandin production in cultured macrophages. Naunyn Schmiedebergs Arch Pharmacol (1981) 1.36

The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis. Brain (2000) 1.35

Leukocytes and prostaglandins in acute inflammation. Experientia (1974) 1.35

Optimized production of high-titer recombinant adeno-associated virus in roller bottles. Biotechniques (2003) 1.31

Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett (1996) 1.30

Immunolocalization of type X collagen in normal fetal and adult osteoarthritic cartilage with monoclonal antibodies. Matrix Biol (1996) 1.30

Sequential changes of biochemical bone parameters after kidney transplantation. Nephrol Dial Transplant (1998) 1.29

Elevated serum cyclophilin levels in patients with severe sepsis. J Clin Immunol (1997) 1.28

GARP: a key receptor controlling FOXP3 in human regulatory T cells. J Cell Mol Med (2009) 1.25

Computerized surveillance of adverse drug reactions in hospital: implementation. Eur J Clin Pharmacol (1999) 1.24

Central effect of the non-steroid anti-inflammatory agents, indomethacin, ibuprofen, and diclofenac, determined in C fibre-evoked activity in single neurones of the rat thalamus. Pain (1990) 1.23

Parameter identification, experimental design and model falsification for biological network models using semidefinite programming. IET Syst Biol (2010) 1.18

Possible role of oxygen free radicals in ethanol-induced gastric mucosal damage in rats. Dig Dis Sci (1988) 1.17

Neutralization of interleukin-1 beta activity in vivo with a monoclonal antibody alleviates collagen-induced arthritis in DBA/1 mice and prevents the associated acute-phase response. Clin Exp Rheumatol (1994) 1.16

Glucose uptake, lactate release, ketone body turnover, metabolic micromilieu, and pH distributions in human breast cancer xenografts in nude rats. Cancer Res (1988) 1.14

Biodistribution of mild analgesics. Br J Clin Pharmacol (1980) 1.12

Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet. Clin Pharmacol Ther (2002) 1.12

Acidic nonsteroid anti-inflammatory drugs accumulating in inflamed tissue. Experientia (1975) 1.11

A sulphonamido-indanone derivative CGP 28237 (ZK 34228), a novel non-steroidal anti-inflammatory agent without gastro-intestinal ulcerogenicity in rats. Drugs Exp Clin Res (1987) 1.11

A novel inhibitor of the tyrosine kinase Src suppresses phosphorylation of its major cellular substrates and reduces bone resorption in vitro and in rodent models in vivo. Bone (1999) 1.11

Microbicidal activity of peroxidaseless chicken heterophile leukocytes. Infect Immun (1972) 1.10

Correlation between antimicrobial activity and peroxidase content of leukocytes. Nature (1973) 1.10

Retrospective analysis of the frequency and recognition of adverse drug reactions by means of automatically recorded laboratory signals. Br J Clin Pharmacol (1999) 1.10

Pharmacokinetics and pharmacodynamics of ketamine enantiomers in surgical patients using a stereoselective analytical method. Br J Anaesth (1993) 1.10

Autosomal dominant juvenile amyotrophic lateral sclerosis and distal hereditary motor neuronopathy with pyramidal tract signs: synonyms for the same disorder? Brain (2002) 1.09

The incidence and significance of hemostatic abnormalities in patients with head injuries. Neurosurgery (1989) 1.09

Impairment and recovery of elementary cognitive function induced by hypoglycemia in type-1 diabetic patients and healthy controls. J Clin Endocrinol Metab (2000) 1.08

Prostaglandin E(2) upregulates cyclooxygenase-2 expression in lipopolysaccharide-stimulated RAW 264.7 macrophages. Biochem Biophys Res Commun (2000) 1.08

Effect of anti-inflammatory and analgesic pyrazoles on arachidonic acid metabolism in isolated heart and gastric mucosa preparations. Agents Actions Suppl (1986) 1.07

Effects of pentazocine and acetylsalicylic acid on pain-rating, pain-related evoked potentials and vigilance in relationship to pharmacokinetic parameters. Agents Actions (1990) 1.06

Induction of growth alterations in factor-dependent hematopoietic progenitor cell lines by cocultivation with irradiated bone marrow stromal cell lines. Blood (1986) 1.05

Stereoselective disposition of flurbiprofen in healthy subjects following administration of the single enantiomers. Br J Clin Pharmacol (1994) 1.05

In vitro activities of tosufloxacin, temafloxacin, and A-56620 against pathogens of diarrhea. Antimicrob Agents Chemother (1990) 1.04

Dissociation between the antinociceptive and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs. A survey of their analgesic efficacy. Drugs (1991) 1.04

A sensitive and efficient induction system for murine IgE. Single cell analysis at the clonal level. J Immunol Methods (1991) 1.04

Phenotype-genotype correlations in a CMT2B family with refined 3q13-q22 locus. Neurology (2000) 1.03

Transport of the new chemotherapeutic agent beta-D-glucosylisophosphoramide mustard (D-19575) into tumor cells is mediated by the Na+-D-glucose cotransporter SAAT1. Proc Natl Acad Sci U S A (1998) 1.03

Ulcero-mutilating neuropathy in an Austrian kinship without linkage to hereditary motor and sensory neuropathy IIB and hereditary sensory neuropathy I loci. Neurology (2000) 1.02

Differential effects of ketamine enantiomers on NMDA receptor currents in cultured neurons. Eur J Pharmacol (1992) 1.02

A new thermoactive pullulanase from Desulfurococcus mucosus: cloning, sequencing, purification, and characterization of the recombinant enzyme after expression in Bacillus subtilis. J Bacteriol (2000) 1.02

Application of microdialysis for the determination of muscle and subcutaneous tissue concentrations after oral and topical ibuprofen administration. Clin Pharmacol Ther (1999) 1.01

Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats. Calcif Tissue Int (2003) 1.01

Thymic epithelial tumors can develop along two different pathogenetic pathways. Am J Pathol (2001) 1.01

Serum antibodies against chondrocyte cell surface proteins in osteoarthritis and rheumatoid arthritis. J Rheumatol (1988) 1.01

Clinical-MRI correlations in a European trial of interferon beta-1b in secondary progressive MS. Neurology (2001) 1.01

Effect of glutamine on protein synthesis in isolated intestinal epithelial cells. JPEN J Parenter Enteral Nutr (1994) 1.01

Computerized survelliance of adverse drug reactions in hospital: pilot study. Br J Clin Pharmacol (1998) 1.00

Cyclooxygenase-2 expression in lipopolysaccharide-stimulated human monocytes is modulated by cyclic AMP, prostaglandin E(2), and nonsteroidal anti-inflammatory drugs. Biochem Biophys Res Commun (2000) 0.99

Suppressed injury-induced rise in spinal prostaglandin E2 production and reduced early thermal hyperalgesia in iNOS-deficient mice. J Neurosci (2000) 0.99

Imprinting centre deletions in two PWS families: implications for diagnostic testing and genetic counseling. Clin Genet (2000) 0.99

Effects of pure enantiomers of flurbiprofen in comparison to racemic flurbiprofen on eicosanoid release from various rat organs ex vivo. Prostaglandins (1991) 0.99

Neonatal herpes prevention: a minor public health problem in some communities. Sex Transm Infect (2000) 0.98

Non-acidic pyrazoles: inhibition of prostaglandin production, carrageenan oedema and yeast fever. Agents Actions (1983) 0.98

Inflammatory models of cutaneous hyperalgesia are sensitive to effects of ibuprofen in man. Pain (1995) 0.98

The effects of GM-CSF and G-CSF in promoting growth of clonogenic cells in acute myeloblastic leukemia. Blood (1987) 0.98

How aspirin might work: a pharmacokinetic approach. Agents Actions (1974) 0.97

Role of the parietal cell in gastric damage induced by aspirin and related drugs: implications for safer therapy. Med J Aust (1976) 0.97

Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis. Neuroradiology (2010) 0.97